ライフサイエンスコーパス: systemic complication

1 d as stable or borderline (increased risk of systemic complications).

2 loss, potentially leading to tooth loss and systemic complications.

3 res have terminated, and identify and manage systemic complications.

4 mic therapy by preventing both the local and systemic complications.

5 address the infection, preventing ocular and systemic complications.

6 and promptly treat the many neurological and systemic complications.

7 of cerebral vasospasm and the management of systemic complications.

8 and treating cerebral vasospasm and managing systemic complications.

9 he modulatory role of type I IFNs to prevent systemic complications.

10 tory response syndrome (SIRS) and subsequent systemic complications.

11 ies protect STEC-infected animals from fatal systemic complications.

12 ome benefit in preventing the development of systemic complications.

13 ression of intestinal disease to more severe systemic complications.

14 ted with impetigo, which can lead to serious systemic complications.

15 nosis can lead to devastating ophthalmic and systemic complications.

16 longevity and a higher prevalence of chronic systemic complications.

17 pathogenesis of hemorrhagic colitis and its systemic complications.

18 y renal failure at 10 years of age and other systemic complications.

19 pancreatitis and responsible for many of its systemic complications.

20 ptibility to granulomatous enterocolitis and systemic complications.

21 SS frequently is associated with ocular and systemic complications.

22 ized by progressive muscle wasting and multi-systemic complications.

23 diagnosis and treatment can cause local and systemic complications.

24 es mellitus (1.22; 1.11-1.35), diabetes with systemic complications (1.34; 1.11-1.62), mild liver dis

25 1029] vs 23.7% [278 of 1174], P < .001) and systemic complications (24.2% [249 of 1029] vs 31.2% [36

26 rs effective in reducing SIRS and subsequent systemic complications after burn injury.

27 EVAR repair with a lower rate of short-term systemic complications and a shorter length of stay comp

28 agulant MPs in proportion to the severity of systemic complications and adverse outcome.

29 the cerebrospinal fluid were associated with systemic complications and death (P= 0.0002).

30 Higher rates of systemic complications and myopia also were identified a

31 ritical for reducing the risk of devastating systemic complications and preserving ocular and visual

32 adverse events (eg, deep vein thrombosis and systemic complications) and minor adverse events (eg, pi

33 ic size ranges are associated with the SIRS, systemic complications, and adverse outcome of ALI/ALF.

34 Death, systemic complications, and length of stay were tabulate

35 rvival benefit, lower incidence of local and systemic complications, and shorter hospitalization.

36 ude that relapsing chronic enterocolitis and systemic complications are in part due to plasma K-K sys

37 ay have therapeutic implications by reducing systemic complications arising from AKI.

38 ay have therapeutic implications by reducing systemic complications arising from hepatic IR.

39 and histologic (P<0.0005) scores as well as systemic complications (arthritis, splenomegaly, hepatom

40 rotein may have a role in the progression of systemic complications associated with acute pancreatiti

41 Given the potentially life-threatening systemic complications associated with BHD, early recogn

42 ecific antibody was protective against fatal systemic complications even when it was administered wel

43 e care stay is shorter, blood loss less, and systemic complications fewer (numbers needed to treat, t

44 ontributor to acute kidney failure and other systemic complications in humans.

45 ga toxin (Stx) alone is capable of producing systemic complications, including hemolytic-uremic syndr

46 ues developed AIDS, and most developed other systemic complications, including SIV-induced encephalit

47 r inflammation with the potential for severe systemic complications is curable with treatment and sho

48 ulminant hepatic failure, a life-threatening systemic complication of liver disease, or a liver-based

49 eprosum (ENL), an inflammatory cutaneous and systemic complication of multibacillary leprosy.

50 eration of fatty acids on local severity and systemic complications of AP.

51 ention and management of both the ocular and systemic complications of hypertension.

52 ents with widespread chorioretinitis died of systemic complications of M. chimaera infection despite

53 , obesity, and the lymphatic system modulate systemic complications of obesity.

54 n humans, in an attempt to decrease risk for systemic complications of periodontal disease such as at

55 dysfunction and their association with other systemic complications of sickle cell disease.

56 Extraglandular systemic complications of SS (ie, vasculitis, interstiti

57 (HuMAbs) protect mice and piglets from fatal systemic complications of Stx2.

58 1DM) results in oxidative stress, leading to systemic complications of T1DM.

59 lay a major role in the local pancreatic and systemic complications of this disease.

60 Local and systemic complications or infections related to specific

61 tive morbidity including cardiopulmonary and systemic complications, or ileus leading to longer hospi

62 cross Asia, associated with neurological and systemic complications; recent work has focused on the p

63 No notable systemic complications related to the IVB injections wer

64 an increased risk of visual loss and severe systemic complications requiring intensive investigation

65 , formation of aortic aneurysms) and chronic systemic complications such as IL-6-mediated osteopenia.

66 t and hypoxemia being a commonly encountered systemic complication, we analyzed radiological, gas exc

67 channel genes ablated - strongly suggesting systemic complications with the in vivo assay.